Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Other Non-Current Liabilities (2021 - 2025)

Historic Other Non-Current Liabilities for Rockwell Medical (RMTI) over the last 10 years, with Q1 2025 value amounting to $2.9 million.

  • Rockwell Medical's Other Non-Current Liabilities rose 1600.0% to $2.9 million in Q1 2025 from the same period last year, while for Mar 2025 it was $2.9 million, marking a year-over-year increase of 1600.0%. This contributed to the annual value of $1.0 million for FY2024, which is 6000.0% down from last year.
  • According to the latest figures from Q1 2025, Rockwell Medical's Other Non-Current Liabilities is $2.9 million, which was up 1600.0% from $1.0 million recorded in Q4 2024.
  • In the past 5 years, Rockwell Medical's Other Non-Current Liabilities ranged from a high of $2.9 million in Q1 2025 and a low of $14000.0 during Q4 2021
  • Moreover, its 5-year median value for Other Non-Current Liabilities was $507000.0 (2021), whereas its average is $1.1 million.
  • In the last 5 years, Rockwell Medical's Other Non-Current Liabilities soared by 1775714.29% in 2023 and then plummeted by 6000.0% in 2024.
  • Quarter analysis of 5 years shows Rockwell Medical's Other Non-Current Liabilities stood at $14000.0 in 2021, then changed by 0.0% to $14000.0 in 2022, then skyrocketed by 17757.14% to $2.5 million in 2023, then crashed by 60.0% to $1.0 million in 2024, then skyrocketed by 190.0% to $2.9 million in 2025.
  • Its last three reported values are $2.9 million in Q1 2025, $1.0 million for Q4 2024, and $1.8 million during Q3 2024.